Vetter, a contract development and manufacturing company has announced plans to build a filling line for syringes at its Ravensburg Vetter South location in Germany. With a capacity to handle batches of up to one million units per day, the line is ideal for the aseptic filling of products such as vaccines.
Vetter said the company will be able to increase its clinical manufacturing capabilities with another new filling line at the Ravensburg facility and with further investments planned in Chicago.
The company offers services including formulation support and customized packaging development at its Vetter Development Service locations in Chicago and Ravensburg, and is set to expand its services for the early clinical phases of new drugs.
Customers can transfer new drugs from early stage phase to commercial manufacturing through Vetter Development Service support and the company’s know-how in process and packaging development in aseptic filling is used to support clinical offering.
Vetter managing director Peter Soelkner said the company is investing in its partnerships with international customers, continuously and strategically.
"In the area of prefilled syringes we provide our partners a full range of service, from small batches manufacturing and support in early clinical stages to high-volume manufacturing for large scale commercial production," Soelkner added.